Cancer Current Affairs - 2019
Category Wise PDF Compilations available at This Link
A new study has claimed that a natural extract derived from the neem tree can potentially be used to treat pancreatic cancer without harming normal, healthy cells.
The study was conducted by scientists from the Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso). The findings were published in the journal Scientific Reports.
- Scientists have tested nimbolide, a compound found in neem leaves against pancreatic cancer in cell lines and mice.
- The results have showed that this natural compound can stop pancreatic cancer’s growth and metastasis without harming healthy, normal cells in vitro and in vivo experiments.
- In the tests, it was also observed that nimbolide was able to reduce the migration and invasion capabilities of pancreatic cancer cells by 70 per cent.
- It was also found that after Nimbolide was induced cancer cells, it reduced the size and number of pancreatic cancer cell colonies by 80 per cent.
Pancreatic cancer has the highest mortality rate among the all other forms of cancers. Around 94 per cent of patients suffering from it die within five years of diagnosis. The cancer grows quickly and there are currently no effective treatments available.
Medicinal values of Neem tree
- Neem is commonly found in India and is regarded as a ‘one tree pharmacy’ in traditional Ayurveda as it has several insecticidal and medicinal uses.
- Neem leaf has antifungal and antibacterial properties and is commonly used as bio-pesticide. Neem oil contains fatty acid and vitamin E
- Most tradional Ayurvedic formulations use it for the treatment of skin disorders because of its detoxifying properties.
China has set up the world’s largest cancer registry system in a bid to fight the cancer diseases with more-targeted and evidence-based intervention programmes.
The cancer registry system is a systematic collection of data about cancer and tumor diseases of Chinese people. The registry records complete summary of cancer patient history including diagnosis, treatment and status of every cancer patient. However the registry excludes the medical costs.
This registry system seeks to cover over 300 million people of China and expand to include 40 per cent of the nation’s population of 1.36 billion by 2020.
In China, at least 3 million people develop cancer each year and it claims 2.2 million lives in China and costs at least US 16 billion dollars each year.